TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/4/24 20:00 | 1/3/24 | DYAI | Dyadic International Inc | DE | Health | BioPrd | Biological Products, (No Diag | Kaye Jack | FL | D | M.d | 0 | 0.00 | 0 | 27 | 424 | 34 | D | |||||||||||||||
6/20/23 17:23 | 6/16/23 | QURE | Uniqure N.V. | Health | Drug | Pharmaceutical Preparations | Kaye Jack | P7 | D | S.d | -43 | 18.93 | 0 | -2 | -6 | 34 | D | ||||||||||||||||
3/1/23 16:10 | 2/27/23 | QURE | Uniqure N.V. | Health | Drug | Pharmaceutical Preparations | Kaye Jack | P7 | D | S | -8 | 19.99 | 0 | 0 | -1 | 28 | D | ||||||||||||||||
3/2/22 17:42 | 2/28/22 | QURE | Uniqure N.V. | Health | Drug | Pharmaceutical Preparations | Kaye Jack | P7 | D | S | -10 | 16.76 | 0 | -1 | -3 | 19 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |